Skip to main content
Kenneth Kehl, MD, Oncology, Boston, MA

Kenneth L Kehl MD


Instructor in Medicine-Hospital Medicine, Northwestern University Medical School

Join to view full profile
  • 450 Brookline AveBoston, MA 02215

  • Phone+1 617-632-3468

Dr. Kehl is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2008

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2028
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • TX State Medical License
    TX State Medical License 2014 - 2019
  • IL State Medical License
    IL State Medical License 2010 - 2014
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Clinical trajectory modeling to predict hospitalization or death after palliative chemotherapy. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Grand Rounds August 1, 2025: Clinical Trial Notifications Triggered by Artificial Intelligence-Detected Cancer Progression (Kenneth L. Kehl, MD, MPH)
    Grand Rounds August 1, 2025: Clinical Trial Notifications Triggered by Artificial Intelligence-Detected Cancer Progression (Kenneth L. Kehl, MD, MPH)August 1st, 2025
  • Biomarker Testing in Advanced Cancer Still Lags Behind Guideline Recommendations
    Biomarker Testing in Advanced Cancer Still Lags Behind Guideline RecommendationsJuly 11th, 2025
  • Harnessing AI and Genomics in Clinical Trial Enrollment
    Harnessing AI and Genomics in Clinical Trial EnrollmentJune 26th, 2025

Grant Support

  • ACTIVATE: AI-driven Clinical Trial Information and Viability Assessment Tool for EHRsDANA-FARBER CANCER INST2025–2030
  • Deep clinical trajectory modeling to optimize accrual to cancer clinical trialsDANA-FARBER CANCER INST2020–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: